$Galera Therapeutics, Inc.(GRTX)$announced topline results from Phase 2a AESOP trial of avasopasem for severe acute radiation-induced esophagitis in lung cancer patients receiving concurrent chemoradiotherapy.
$Cidara Therapeutics(CDTX)$Based on the forecasts from 5 analysts, the average analyst target price for Cidara Therapeutics Inc is USD 6.45 over the next 12 months. Cidara Therapeutics Inc’s average analyst rating is Strong Buy. [Onlooker]
$Cidara Therapeutics(CDTX)$Rezafungin Awarded Promising Innovation Medicine (PIM) Designation by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Invasive Candidiasis